Sponsor pipeline

Fred Hutchinson Cancer Center clinical trial pipeline

Get alerts when Fred Hutchinson Cancer Center's trials change

96 active trials 58 recruiting 2 Phase 3 31 disease areas 29 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-12
Recruitment suspended
Recruitment suspended: Insufficient funding
NCT07098364 ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in… · Phase 1/2
2026-09-12
Withdrawn before enrolling
Trial withdrawn: Study withdrawn before opening to accrual.
NCT04579523 ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and… · Phase 1
2026-09-03
Trial terminated
Trial terminated: Terminated due to low accrual.
Final enrollment: 10 participants (planned 30)
Primary completion confirmed: June 2026 (last estimated January 2027)
NCT05930496 Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III…
2026-09-25
Primary completion pushed: 2027-08-31 → 2027-12-31
Completion pushed: 2028-05-31 → 2028-12-31
NCT07390916 Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen…
2026-09-25
Primary completion pushed: 2027-05-31 → 2027-12-31
Completion pushed: 2027-05-31 → 2027-12-31
NCT07645378 Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer…
2026-09-25
Primary completion pushed: 2027-05-31 → 2027-12-31
Completion pushed: 2027-05-31 → 2027-12-31
NCT07645352 Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer…
2026-09-25
Primary completion pushed: 2027-05-31 → 2027-12-31
Completion pushed: 2027-05-31 → 2027-12-31
NCT07468695 Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical…
2026-09-05
Phase changed: Phase 3 → not applicable
Results posted: 2026-09-04
NCT04409236 Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
2026-09-22
Trial completed
NCT05359211 NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or… · Phase 1
2026-09-18
Recruitment opened
Start date moved earlier: 2026-12-01 → 2026-10-15
NCT07667335 Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable… · Phase 1/2
2026-09-04
Enrollment closed, study ongoing
Final enrollment: 45 participants (planned 68)
NCT03779854 Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and… · Phase 2
2026-09-04
Recruitment opened
NCT06771739 A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
2026-09-03
Trial completed
Final enrollment: 70 participants (planned 80)
Primary completion confirmed: May 2026 (last estimated August 2026)
NCT06609057 Cooking for Your Health in Southern New Mexico: an 8-week, Bilingual (English and…
2026-09-26
Primary completion moved earlier: 2028-12-31 → 2027-08-31
Completion moved earlier: 2028-12-31 → 2027-08-31
NCT03779854 Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and… · Phase 2

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-14 NCT07819396 Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host… Phase 2 Not Yet Recruiting
2026-09-04 NCT07803653 IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
10
Phase 1/2
9
Phase 2
29
Phase 3
2
Not charted: 46 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 96

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06811038 iCanQuit Smoking Cessation Among Hispanic Adults Cigarette Smoking-Related Carcinoma Not Yet Recruiting 2026-09-21
NCT04447313 Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study Obesity-Related Malignant Neoplasm Active, Not Recruiting 2025-11-24
Phase 2
NCT06817889 Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in… Hematopoietic and Lymphatic System Neoplasm Recruiting 2026-10-01
NCT07011810 Axatilimab for Sclerotic Chronic Graft-versus-Host Disease Chronic Graft Versus Host Disease Recruiting 2026-09-24
NCT05996627 Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host… Chronic Graft Versus Host Disease Recruiting 2026-09-17
NCT03980769 Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating… Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder Recruiting 2026-09-16
NCT07194980 Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory… Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recruiting 2026-09-11
NCT07228624 Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With… Myelodysplastic/Myeloproliferative Neoplasm Recruiting 2026-08-19
NCT07209371 Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal… IgA Monoclonal Gammopathy of Undetermined Significance Recruiting 2026-08-17
NCT06145633 Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic… Castration-Resistant Prostate Carcinoma Recruiting 2026-08-06
NCT06013423 Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in… Acute Leukemia of Ambiguous Lineage Recruiting 2026-07-22
NCT04370301 Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or… Primary Myelofibrosis Recruiting 2026-07-20
NCT07046078 Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body… Acute Leukemia of Ambiguous Lineage Recruiting 2026-07-20
NCT05952804 IVIG for Infection Prevention After CAR-T-Cell Therapy Hematologic Malignancies Recruiting 2026-06-29
NCT04195633 Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for… Acute Leukemia Recruiting 2026-05-29
NCT04941716 Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent… Recurrent Chronic Lymphocytic Leukemia Recruiting 2026-05-18
NCT06839053 Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic… Chronic Lymphocytic Leukemia Recruiting 2026-04-22
NCT03970096 Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant… Acute Leukemia Recruiting 2026-03-12
NCT03779854 Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and… Acute Biphenotypic Leukemia Active, Not Recruiting 2026-09-25
NCT07390968 Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult… Hematopoietic and Lymphatic System Neoplasm Not Yet Recruiting 2026-09-17
NCT07576725 Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic… Clinical Stage III Cutaneous Melanoma AJCC v8 Not Yet Recruiting 2026-09-17
NCT07819396 Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host… Acute Biphenotypic Leukemia Not Yet Recruiting 2026-09-14
NCT07466498 Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic… Castration-Sensitive Prostate Adenocarcinoma Not Yet Recruiting 2026-08-31
NCT06026371 Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in… Acute Graft Versus Host Disease Active, Not Recruiting 2026-07-20
NCT03399773 Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in… Acute Biphenotypic Leukemia Active, Not Recruiting 2026-07-10
See all 96 active Fred Hutchinson Cancer Center trials with filters →

Disease areas by active trials, top 10 of 31

Leukemia (20) · Acute Myeloid Leukemia (AML) (15) · Myelodysplastic Syndromes (MDS) (14) · Acute Lymphoblastic Leukemia (ALL) (9) · MDS/MPN Overlap (9) · Lung Cancer (6) · Prostate Cancer (6) · Chronic Lymphocytic Leukemia (CLL) (5) · Chronic Myeloid Leukemia (CML) (5) · Breast Cancer (4)

Get alerts when Fred Hutchinson Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free